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Abstract
Background: The genetic basis of autosomal dominant nonsyndromic hearing loss is complex. Genetic factors are
responsible for approximately 50% of cases with congenital hearing loss. However, no previous studies have
documented the clinical phenotype and genetic basis of autosomal dominant nonsyndromic hearing loss in
Mongolians.
Methods: In this study, we performed exon capture sequencing of a Mongolian family with hereditary hearing loss
and identified a novel mutation in TECTA gene, which encodes α -tectorin, a major component of the inner ear
extracellular matrix that contacts the specialized sensory hair cells.
Results: The novel G→ T missense mutation at nucleotide 6016 results in a substitution of amino acid aspartate at
2006 with tyrosine (Asp2006Tyr) in a highly conserved zona pellucida (ZP) domain of α-tectorin. The mutation is not
found in control subjects from the same family with normal hearing and a genotype-phenotype correlation is
observed.
Conclusion: A novel missense mutation c.6016 G > T (p.Asp2006Tyr) of TECTA gene is a characteristic TECTA-related
mutation which causes autosomal dominant nonsyndromic hearing loss. Our result indicated that mutation in
TECTA gene is responsible for the hearing loss in this Mongolian family.
Keywords: TECTA gene, Mongolian family, Autosomal dominant nonsyndromic hearing loss
Background
Hearing loss is one of the most common sensory disor-
ders in humans. Genetic factors are responsible for ap-
proximately 50% of cases with congenital hearing loss
[1,2]. While 30% of hereditary hearing loss are syn-
dromic associated with specific signs and medical prob-
lems, the other 70% are nonsyndromic [3]. The heredity
of nonsyndromic hearing loss has recessive and domin-
ant modes of inheritance. It is estimated that 80% of
genetic forms of hearing loss is autosomal recessive and
the remaining 20% is autosomal dominant [2]. Auto-
somal dominant nonsyndromic hearing loss (ADNSHL)
is represented by heterogeneity of genetic and clinical
features. To date, about 60 loci associated with ADNSHL
have been mapped but only 24 genes have been iden-
tified [4].
As one of causative genes of ADNSHL, TECTA muta-
tions have been identified in various types of hearing
loss, age of onset, progression and frequency involve-
ment in various populations [5-13]. This gene encodes
α-tectorin, the major noncollagenous component of tec-
torial membrane which contacts the outer cochlear hair
cells and has an important role in intracochlear sound
transmission [14]. The α-tectorin is composed of three
distinct modules: the entactin G1 domain, the zonadhe-
sin (ZA) domain and the zona pellucida (ZP) domain
[14]. Missense and nonsense mutations in the entactin
G1 domain and ZP domain are associated with hearing
impairment at mid-frequency, whereas mutations in the
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ZA domain primarily affect hearing at the high frequen-
cies [13,15]. Phenotypes of hearing loss associated with
TECTA can range from mild to severe and have pre or
postlingual onset [13].
In this study, we examined the genetic basis of ADSHNL
in a Mongolian family with hereditary hearing loss by
exon-capture sequencing of known genes associated with
hearing loss and identified a novel mutation in TECTA
gene. This novel mutation causes the aspartate to tyrosine
substitution (Asp2006Tyr) in the highly conserved ZP do-
main of α-tectorin. We further studied the genotype-
phenotype correlation of mutation in TECTA gene with
control subjects from the same family with normal hearing
and confirmed that mutation in TECTA gene is respon-
sible for the hearing loss in this Mongolian family.
Methods
Subjects
Patients of a Mongolian family suffered severe hearing
impairment were diagnosed in the Affiliated Hospital of
Inner Mongolia University for the Nationalities. Clinical
examination showed that none of these patients has any
other associated neurological signs, visual dysfunction or
diabetes mellitus. Nineteen members of this Mongolian
family participated in the study, of which fourteen
showed clinical symptoms of hearing impairment. The
study protocol was approved by the Committee on Clin-
ical Investigation at the Inner Mongolia University for the
Nationalities University. Informed written consent was
obtained from all study participants and the study was
in accordance with regulations by the Inner Mongolia
University for the Nationalities University.
Audiometric evaluation
Hearing impairment was evaluated by pure tone audi-
ometry (PTA) in a sound-controlled room at frequencies
ranging from 500 to 8000 Hz, according to standard pro-
tocols. The severity of hearing loss was defined as follows
based on the mean PTA using the thresholds measured
at 500, 1000, 2000, and 3000 Hz: normal hearing, below
20 dB; mild hearing impairment, 21 - 40 dB; moderate
hearing impairment, 41 - 70 dB; severe hearing impair-
ment, 71 – 95 dB; and profound hearing impairment, > 95
dB [16]. The range of hearing loss was described as fol-
lows depending on the PTA: low frequency, 125 - 1000
Hz; mid-frequency, 1000 - 4000 Hz; and high frequency,
4000 - 8000 Hz.
Target exon capture sequencing
Approximately 4 mL of peripheral blood were collected
from each study participant and genomic DNA was ex-
tracted using the QIAamp DNA Blood Mini Kit (Qiagen,
Hilden, Germany). The qualified genomic DNA sample
of the affected subject III21 was randomly fragmented by
Covaris (Covaris S2, Massachusetts, USA) into segments
ranging from 200 bp to 300 bp. These DNA fragments
were purified and quantified, and then adapters were li-
gated to both ends. After amplified by ligation-mediated
PCR (LM PCR), adapter-DNA fragments were hybrid-
ized to the capture-array of BGI (BGI, Shenzhen, China)
to capture all target genes for 72h. After washing off
non-hybridized fragments, captured library which con-
tains the targeted exon sequences of 54 known genes as-
sociated with hearing loss was loaded on the Hiseq2000
platform (Illumina, San Diego, USA). Raw image files
were processed by Illumina base calling Software 1.7 for
base calling with default parameters and the sequences
were generated as 90bp paired-end reads.
After removing adapter sequences and low quality se-
quence reads from the raw data, the remaining clean
reads were mapped and aligned to the human reference
genome (NCBI build 37.1/hg19) using Burrows Wheeler
Aligner (BWA). SNPs and indels (insertion and deletion)
were called by SOAPsnp and GATK (http://www.broad-
institute.org/gsa/wiki/index.php/, The Genome Analysis
Toolkit), respectively. All variants of the samples were fil-
tered by databases including dbSNP137 (http://hgdownload.
cse.ucsc.edu/goldenPath/hg19/database/snp137.txt.gz), Hap-
Map project (ftp://ftp.ncbi.nlm.nih.gov/hapmap), 1000
Genome Project (ftp://ftp.1000genomes.ebi.ac.uk/vol1/
ftp), and an in-house database of BGI. After filtering,
variants were further analyzed by SIFT and PolyPhen
to predict the effect of mutation on the function of
encoding proteins. Only variants that had significant
impact on the function of the target protein were fur-
ther analyzed.
Sanger sequencing
Candidate variants observed via target exon capture se-
quencing were screened in other family members who
participated the study using conventional capillary se-
quencing. Briefly, DNA fragments containing variants
were PCR amplified from 10-40 ng of genomic DNA
using a touch down protocol with primers listed in
Table 1. PCR products were visualized on agarose gels,
purified with Sephadex columns in accordance with the
manufacturers’ protocols. Sequence analysis was per-
formed with the Big Dye Terminator Cycle Sequencing
Kit and the ABI PRISM 3730 DNA Analyzer (Applied
Table 1 Primers of TECTA and SLC26A4 gene
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Biosystems). Sequence traces were analyzed using the
Sequencher 4.7 program (Gene Codes Corporation).
Results
ADSHNL diagnosis and clinical study
We ascertained a Mongolian family with autosomal
dominant nonsyndromic hearing loss. The pedigree
comprises four generations with 19 affected family mem-
bers (9 males and 10 females), 14 of whom are willing to
participate in this study (Figure 1). There was no evi-
dence of any other cause of hearing impairment, except
for one patient who had undergone stapes replacing sur-
gery for unilateral otosclerosis. This patient was included
in this study but only audiometric data from her other
non-surgical ear were used. The first symptoms of hear-
ing impairment were self-reported at ages ranging from
1 to 69 years. No vestibular symptoms were reported.
Otoscopy was normal in all subjects except the above-
mentioned patient. Pure tone audiograms (PTA) were
symmetric and often displayed a so-called cookie-bite
shape, which indicates that the survey frequencies are
predominantly affected (Figure 2). The highest threshold
was most often found at 1000 Hz and followed by 2000
Hz. The PTA was usually within the range of 40–120 dB
and apparently independent of age. By contrast, the PTA
from control subjects with normal hearing was in the
range of 0–40 dB (Figure 2).
Identification of candidate mutation
To understand the genetic basis underlying the hearing
loss in this Mongolian family, we took the candidate
gene approach to screen 54 known hearing loss associ-
ated genes with exon capture followed by deep sequen-
cing of the DNA sample from the patient III21. We then
analyzed the SNPs and indels mutation from sequen-
cing reads. The bioinformatic analysis identified four
missense variants (p.Arg371Gly, p.Val932Ala, p.Ser1724-
Asn and p.Asp2006Tyr) and four synonymous variants
(p.Ala495Ala, p.Ile752Ile, p.Tyr935Tyr, p.Ser1878Ser)
in coding region of TECTA (Table 2), which encodes
α-tectorin, a major component of the inner ear extracel-
lular matrix that contacts the specialized sensory hair
cells. One missense mutation (p.Cys282Gly) in SLC26A4
was also called in the aforementioned analyzed strategy.
No other mutation was identified in the rest of known
hearing loss associated genes, including ACTG1, CCDC50,
COCH, COL11A2, DFNA5, DIAPH1, and EYA4 et al. for
this patient sample.
The sequencing coverage of every exon of TECTA was
up to 99%, and the depth of each exon was close to the
average median-depth across 23 exons, indicating se-
quencing in our study is deep enough for identifying all
possible variants (Figure 3B). This suggests the above-
mentioned variants are the possible causative mutations
impairing the hearing of this Mongolian family. To narrow
down the candidate variants of TECTA, we then filtered
these variants with four databases (dbSNP, HapMap, 1000
project and in-house database of BGI) with a minor allele
frequency (MAF) of 0.005. Only p.Asp2006Tyr was left
after filtering, suggesting a novel variant in TECTA.
Genotype-phenotype correlation study
The TECTA gene is known as a causative gene for
DFNA8/DFNA12 and DFNB21 hearing loss in humans,
and SLC26A4 is related to autosomal recessive hearing
loss. The missense mutations p.Asp2006Tyr of α-
tectorin and p.Cys282Gly of SLC26A4 are heterozygous,
which fits the autosomal dominant inheritance model.
These two mutations have not been reported previously
based on the public databases. The p.Asp2006Tyr of
α-tectorin and p.Cys282Gly of SLC26A4 were predicted
to be pathogenic mutations by SIFT and PolyPhen. Thus,
p.Asp2006Tyr of α-tectorin and p.Cys282Gly of SLC26A4
were considered as candidate causative mutations of
hearing loss in the studied Mongolian family. There-
fore, we further screened these mutations in other af-
fected subjects using Sanger sequencing for a genotype
phenotype correlation analysis with primers listed in
Table 1.
Figure 1 Pedigree of the Mongolian family. Black and white symbols indicate the affected and the unaffected subjects, respectively.
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Sequencing of three patients and three control subjects
in the family showed that c.844 T > G (p.Cys282Gly)
in SLC26A4 is also present in controls, ruling out the
association of p.Cys282Gly in SLC26A4 with hearing
loss in the studied Mongolian family. We then con-
firmed the presence of the novel missense mutations
c.6016 G > T (p.Asp2006Tyr) of the TECTA gene in
exon 20 of the rest of all 13 participated subjects
with hereditary hearing loss (Figure 4B). The affected
members in this family (II-2, III-3, III-5, and III-10)
were heterozygous for the mutation, but not detected
in the II-1. This is consistent with a complete segre-
gation of the variant allele with the phenotype status
in this family (Figures 1 and 4B). This mutation is
II-5 (64 yrs old) II-7 (60 yrs old)
IV-14 (28 yrs old)III-21 (34 yrs old)
II-8 (55 yrs old)
III-3 (53 yrs old)
III-7 (51 yrs old) III-11 (43 yrs old)
A
B
II-3 (69 yrs old)
Figure 2 Pure tone audiometry recording of representative members in the Mongolian family. A. audiograms of six different patients in
three generations (only audiograms of left ear is shown). X: frenquency; Y: intensity (dB). B. audiograms of the left ear of three different control
subjects in two generations. The age of each subject at the time of tested was indicated.
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located in the ZP domain of α-tectorin which is
highly conserved across species (Figure 4C). We fur-
ther sequenced DNAs of all the normal control sub-
jects of the family, plus screened additional 201
healthy individuals from a random Mongolian popula-
tion sample that we have deep sequencing data. We
did not find the presence of the above-mentioned p.
Asp2006Tyr mutation in the TECTA gene (data not
shown), demonstrating the genotype-phenotype cor-
relation of the mutation in TECTA gene with the
hearing loss in the Mongolian family.
Discussion
TECTA encodes α-tectorin, the major component of
extracellular matrix contacting cochlear hair cells and
transmitting sounds [14]. Mutations in α-tectorin have
been detected in ADNSHL in various populations across
different ages of onset and progressions [5-13], account-
ing for ~4% of all cases [13]. Interestingly, previous
studies showed that mutations affecting three different
domains (entactin G1 domain, ZA domain, and ZP)
present clinically different phenotypes. Missense mu-
tations on the ZA domain are normally affecting hearing
at the high frequencies, whereas mutations on entactin
G1 domain and ZP domain are linked to mid-frequency
hearing impairment [13,15]. ADNSHL patients with mu-
tations in α-tectorin display various severity and onset of
hearing loss [13].
In this study, we did exon-capture followed by next-
generation sequencing to screen 54 known hearing-loss
associated genes for mutations in a Mongolian family
with hereditary hearing loss. We identified four mis-
sense variants (p.Arg371Gly, p.Val932Ala, p.Ser1724Asn
and p.Asp2006Tyr) and four synonymous variants
(p.Ala495Ala, p.Ile752Ile, p.Tyr935Tyr, p.Ser1878Ser)
in coding regions of TECTA. Among these, a novel
variant, p.Asp2006Tyr was found to be implicated as
the pathogenic missense mutation causing hearing loss.
All TECTA mutations described to date have shown
significant genotype-phenotype correlation with hearing
loss [5-13]. In our study, the novel heterozygous mutation
p.Asp2006Tyr on TECTA is only present in affected mem-
bers of the family and is not found in any of the control
subjects in the family plus a fairly large population sample
of the same ethic group. Consistent to previous reports
that mutations on the ZP domains are associated with
mid-frequency hearing loss, the hearing of affected sub-
jects was predominantly affected at the frequency between
1000 Hz and 2000 Hz. The clinical phenotype of hearing
loss in this family displays early onset (as early as 1 year
old). However, no correlation between age and severity of
hearing impairment has been observed.
Several recently developed mouse lines with human
mutations on Tecta provide extremely useful informa-
tion for understanding the mechanism of hearing loss
in the affected families [17-19]. Mice with missense
mutation in the ZP domain of Tecta (TectaY1870C/+,
TectaL1820F,G18724D/+ and TectaC1837G/+) display hearing
loss in mild-frequency range, phenocopying the clinical
observation with affected patients [17,19]. By contrast, the
hearing impairment in mice carrying missense muta-
tion in the ZA domain of Tecta (TectaC1509G/+ and
TectaC1619S/+) is more subtle and slightly different from
what had been reported in patients [18,19]. While the
TectaC1509G/+ mouse had increased reverse transduction
[18], the TectaC1619S/+ mouse was surprisingly found to
have a stable rather than progressive deterioration hearing
phenotype [19]. The authors suggested the genetic traits
of the mouse lines could be a possible explanation for the
different deafness phenotype in mouse and human caused
by the same mutation. Likewise, the age-independency of
hearing loss in the large Mongolian family under this
study is probably dues to the slight difference in their indi-
vidual genetic background. A knockin mouse line with
TectaD1619Y/+ will be very useful to investigate how the
point mutation identified in current study affects the onset
of deafness under various mouse genetic backgrounds.
This novel variation p.Asp2006Tyr in the ZP domain
was a substitution of aspartate with a hydrophilic side
chain to tyrosine with a hydrophilic-neutral chain. Previ-
ously, various mutations in the ZP domain (C1837G,
R2021H, and Y1870C) of TECTA had been shown
Table 2 Mutations identified by exon-capture sequencing
Variants Rs_ID MAF-dbSNP MAF-HapMap MAF-1K project MAF-in-house
p.Arg371Gly rs612969 0.5 0.394 0.4432 0.3892
p.Ala495Ala rs536069 0.629 0.533 0.6007 0.4627
p.Ile752Ile rs10502247 0.449 0.474 0.402 0.4988
p.Val932Ala rs520805 - 0.387 0.3526 0.3843
p.Tyr935Tyr rs586473 0.588 0.504 0.5696 0.4663
p.Ser1724Asn rs526433 - 0.993 0.9936 0.9964
p.Ser1878Ser rs2155369 - 0.314 0.2244 0.4181
p.Asp2006Tyr novel - - 0 0
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within the cytoplasm, suggesting the defect for the mu-
tants to be secreted outside of the cell properly [20]. It
seems likely that the p.Asp2006Tyr mutation in the
ZP domain from this study might also cause similar
defects in the secretion of α -tectorin. However, it is
of note that the secretion defect of mutations in the
ZP domain was drawn from truncated constructs of
TECTA without N-terminal secretion peptide signal.
Further cellular studies with full-length constructs are
necessary to elucidate the exact mechanism of α-
tectorin’s role in ADNSHL.
Conclusion
This study documents a novel missense mutations c.6016
G > T (p.Asp2006Tyr) of the TECTA gene that causes
autosomal dominant nonsyndromic hearing loss in a
Mongolian family. This expands the mutation spectrum of
TECTA gene in nonsyndromic hearing loss. Our study
Figure 3 Genomic DNA extraction and TECTA exon-capture sequencing report. A. Agarose gel examination of genomic DNA quality. 1:I2; 2:
II3; 3:III15; 4: III7;5: IV6; 6: II2;7: II7;8: II5;9: II8;10: III3; 11: III10;12: III21;13: III26;14: III28;15: IV4;16: IV14; 17:IV18. B. TECTA exon-capture sequencing report.
Mean depth(X): the sequencing depth of each exon. Median depth(X): This number of depth is the median depth when depth of all sites was in
an ascending sort. Coverage (%): Divide the total length of the target regions by bases generated by sequencing.




Figure 4 Sequencing analysis of novel missense mutation in exon 20 of TECTA. A. Agarose gel analysis of PCR product TECTA exon 20. 1:I2;
2:II3; 3:III15; 4: III7;5: IV6; 6: II2;7: II7;8: II5;9: II8;10: III3; 11: III10;12: III21;13: III26;14: III28;15: IV4;16: IV14; 17:IV18. B. Representative Sanger sequencing
trace showing heterozygous missense mutation at G6016T (arrow) from patients and control subjects. C. Multi-species alignment of amino acids
encoded by exon 20 of TECTA across different vertebrates. The conserved aspartate residue is highlighted in red.
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also exemplifies the application of deep sequencing in
identifying disease causative mutations from a pedigree.
Competing interests
The authors declare that they have no competing interests with respect to
the present article.
Authors’ contributions
HB designed the study and family recruitment, performed experiments,
analyzed and interpreted the data, drafted the manuscript and obtained
funding. QW designed the study, conducted clinical diagnoses and obtained
funding. XY selected and designed the targets capture, performed
experiments, analyzed and interpreted the data. T conceived of the study
concept, drafted the manuscript, and analyzed and interpreted the data. NN
supervised the study design. YL analyzed and interpreted the data. All other
authors provided technical assistance, and all authors read and approved the
final manuscript.
Acknowledgements
We thank each member of the family for their generous participation in this
study. This study was supported by the National Natural Science Foundation
of China (81160101,81060098).
Author details
1Inner Mongolia University for the Nationalities, Tongliao, Inner 028000,
Mongolia. 2BGI-Shenzhen, Shenzhen, Guangdong 518083, China. 3Genome
Technology Branch, National Human Genome Research Institute, National
Institutes of Health, Bethesda, MD, USA. 4Department of Developmental
Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Received: 10 November 2013 Accepted: 12 March 2014
Published: 19 March 2014
References
1. Friedman TB, Griffith AJ: Human nonsyndromic sensorineural deafness.
Annu Rev Genomics Hum Genet 2003, 4:341–402.
2. Morton CC, Nance WE: Newborn hearing screening–a silent revolution.
N Engl J Med 2006, 354(20):2151–2164.
3. Smith RJH, Shearer AE, Hildebrand MS, Van Camp G: Deafness and
hereditary hearing loss overview. In GeneReviews. Edited by Pagon RA,
Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K. University of
Washington, Seattle; 1993-2014. [http://www.ncbi.nlm.nih.gov/books/
NBK1434/]
4. Hereditary hearing loss homepage. [http://hereditaryhearingloss.org]
5. Iwasaki S, Harada D, Usami S, Nagura M, Takeshita T, Hoshino T: Association
of clinical features with mutation of TECTA in a family with
autosomal dominant hearing loss. Arch Otolaryngol Head Neck
Surg 2002, 128(8):913–917.
6. Verhoeven K, Van Laer L, Kirschhofer K, Legan PK, Hughes DC, Schatteman I,
Verstreken M, Van Hauwe P, Coucke P, Chen A, Smith RJ, Somers T, Offeciers
FE, Van de Heyning P, Richardson GP, Wachtler F, Kimberling WJ, Willems PJ,
Govaerts PJ, Van Camp G: Mutations in the human alpha-tectorin gene
cause autosomal dominant non-syndromic hearing impairment. Nat Genet
1998, 19(1):60–62.
7. Pfister M, Thiele H, Van Camp G, Fransen E, Apaydin F, Aydin O,
Leistenschneider P, Devoto M, Zenner HP, Blin N, Nürnberg P, Ozkarakas H,
Kupka S: A genotype-phenotype correlation with gender-effect for
hearing impairment caused by TECTA mutations. Cell Physiol Biochem
2004, 14(4–6):369–376.
8. Balciuniene J, Dahl N, Jalonen P, Verhoeven K, Van Camp G, Borg E,
Pettersson U, Jazin EE: Alpha-tectorin involvement in hearing disabilities:
one gene–two phenotypes. Hum Genet 1999, 105(3):211–216.
9. Alloisio N, Morle L, Bozon M, Godet J, Verhoeven K, Van Camp G, Plauchu H,
Muller P, Collet L, Lina-Granade G: Mutation in the zonadhesin-like domain
of alpha-tectorin associated with autosomal dominant non-syndromic
hearing loss. Eur J Hum Genet 1999, 7(2):255–258.
10. Hughes DC, Legan PK, Steel KP, Richardson GP: Mapping of the alpha-
tectorin gene (TECTA) to mouse chromosome 9 and human chromosome
11: a candidate for human autosomal dominant nonsyndromic deafness.
Genomics 1998, 48(1):46–51.
11. Plantinga RF, de Brouwer AP, Huygen PL, Kunst HP, Kremer H, Cremers CW:
A novel TECTA mutation in a Dutch DFNA8/12 family confirms
genotype-phenotype correlation. J Assoc Res Otolaryngol 2006,
7(2):173–181.
12. Moreno-Pelayo MA, del Castillo I, Villamar M, Romero L, Hernandez-Calvin
FJ, Herraiz C, Barbera R, Navas C, Moreno F: A cysteine substitution in the
zona pellucida domain of alpha-tectorin results in autosomal dominant,
postlingual, progressive, mid frequency hearing loss in a Spanish family.
J Med Genet 2001, 38(5):E13.
13. Hildebrand MS, Morin M, Meyer NC, Mayo F, Modamio-Hoybjor S, Mencia A,
Olavarrieta L, Morales-Angulo C, Nishimura CJ, Workman H, DeLuca AP,
del Castillo I, Taylor KR, Tompkins B, Goodman CW, Schrauwen I, Wesemael
MV, Lachlan K, Shearer AE, Braun TA, Huygen PL, Kremer H, Van Camp G,
Moreno F, Casavant TL, Smith RJ, Moreno-Pelayo MA: DFNA8/12 caused by
TECTA mutations is the most identified subtype of nonsyndromic
autosomal dominant hearing loss. Hum Mutat 2011, 32(7):25–834.
14. Legan PK, Lukashkina VA, Goodyear RJ, Kossi M, Russell IJ, Richardson GP:
A targeted deletion in alpha-tectorin reveals that the tectorial
membrane is required for the gain and timing of cochlear feedback.
Neuron 2000, 28(1):273–285.
15. Plantinga RF, Cremers CW, Huygen PL, Kunst HP, Bosman AJ: Audiological
evaluation of affected members from a Dutch DFNA8/12 (TECTA) family.
J Assoc Res Otolaryngol 2007, 8(1):1–7.
16. Lee KY, Choi SY, Bae JW, Kim S, Chung KW, Drayna D, Kim UK, Lee SH:
Molecular analysis of the GJB2, GJB6 and SLC26A4 genes in Korean
deafness patients. Int J Pediatr Otorhinolaryngol 2008, 72(9):1301–1309.
17. Legan PK, Lukashkina VA, Goodyear RJ, Lukashkin AN, Verhoeven K, Van
Camp G, Russell IJ, Richardson GP: A deafness mutation isolates a
second role for the tectorial membrane in hearing. Nat Neurosci
2005, 8(8):1035–1042.
18. Xia A, Gao SS, Yuan T, Osborn A, Bress A, Pfister M, Maricich SM, Pereira FA,
Oghalai JS: Deficient forward transduction and enhanced reverse
transduction in the alpha tectorin C1509G human hearing loss mutation.
Dis Model Mech 2010, 3(3–4):209–223.
19. Legan PK, Goodyear RJ, Morin M, Mencia A, Pollard H, Olavarrieta L,
Korchagina J, Modamio-Hoybjor S, Mayo F, Moreno F, Richardson GP: Three
deaf mice: mouse models for TECTA-based human hereditary deafness
reveal domain-specific structural phenotypes in the tectorial membrane.
Hum Mol Genet 2014. Epub ahead of print.
20. Moteki H, Nishio SY, Hashimoto S, Takumi Y, Iwasaki S, Takeichi N, Fukuda S,
Usami S: TECTA mutations in Japanese with mid-frequency hearing loss
affected by zona pellucida domain protein secretion. J Hum Genet 2012,
57(9):587–592.
doi:10.1186/1471-2350-15-34
Cite this article as: Bai et al.: A rare novel mutation in TECTA causes
autosomal dominant nonsyndromic hearing loss in a Mongolian family.
BMC Medical Genetics 2014 15:34.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bai et al. BMC Medical Genetics 2014, 15:34 Page 8 of 8
http://www.biomedcentral.com/1471-2350/15/34
